Latest Boehringer Ingelheim Stories

2014-04-02 04:21:07

LAUSANNE, Switzerland and HAMBURG, Germany, April 2, 2014 /PRNewswire/ -- - Innovative partnership based on Evotec's Target X projects

2014-03-31 04:20:51

CAMBRIDGE, England, March 31, 2014 /PRNewswire/ -- Convergence Pharmaceuticals Holdings Limited ("Convergence"), the company focused on the development of novel and high

2014-03-28 08:27:23

Cardiologists also believe their patients' top concern is the fear of experiencing a clot that leads to a stroke; real-world challenges may influence treatment decisions RIDGEFIELD, Conn.,

2014-03-24 20:23:52

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/skgh5l/investigation) has announced the addition of the "Investigation

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014

2014-03-22 23:04:44

A new lawsuit was filed on March 19, by a widow in Pennsylvania Eastern District Court alleging that her husband died from renal failure and intracerebral hemorrhage caused by Pradaxa.

2014-03-21 08:24:55

Positive opinion is based on data from one of the largest clinical registration programs in its class, involving more than 13,000 adults with type 2 diabetes RIDGEFIELD, Conn.

2014-03-20 23:33:37

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that John Olszewski of Boehringer Ingelheim USA will speak at Pharmica’s SharePoint

2014-03-19 23:31:58

According to a Court Order filed in March 13, new sanctions were imposed on Boehringer Ingelheim for Pradaxa Multidistrict Litigation discovery abuses.

Word of the Day
  • totally perplexed and mixed up.
The word 'metagrabolized' is also spelled 'metagrobolized'.